RECENT DEVELOPMENTS IN THE PREVENTION OF RHEUMATIC FEVER
Authors: Harold B. Houser, George C. Eckhardt
Journal: Annals of Internal Medicine (1952)

Article1 November 1952RECENT DEVELOPMENTS IN THE PREVENTION OF RHEUMATIC FEVERHAROLD B. HOUSER, GEORGE C. ECKHARDTHAROLD B. HOUSER, GEORGE C. ECKHARDTAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-37-5-1035 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDuring the past decade developments in the control and prevention of rheumatic fever have occurred which, when fully applied, should reduce the incidence of a disease that is a major cause of death in children and an important cause of chronic disability in both children and adults.It is now well established that attacks of rheumatic fever are usually, if not always, initiated by a preceding group A streptococcal respiratory infection. Recently developed technics which have been successful in lowering the incidence of rheumatic fever have been directed toward this streptococcal infection. Two methods utilizing these technics are now available...Bibliography1. Atwater RM: Studies in the epidemiology of acute rheumatic fever and related diseases in the United States, based on mortality statistics, Am. J. Hyg. 7: 343, 1927. Google Scholar2. CoburnYoung AFDC: The epidemiology of hemolytic streptococcus, 1949, Williams and Wilkins, Baltimore. Google Scholar3. GoernerMassellJones JRBFTD: Use of penicillin in the treatment of carriers of beta hemolytic streptococci among patients with rheumatic fever, New England J. Med. 237: 576, 1947. CrossrefMedlineGoogle Scholar4. KilbourneLoge EDJP: The comparative effects of continuous and intermittent penicillin therapy on the formation of antistreptolysin in hemolytic streptococcal pharyngitis, J. Clin. Investigation 27: 418, 1948. CrossrefMedlineGoogle Scholar5. HouserEckhardtHahnDennyWannamakerRammelkamp HBGCEOFWLWCH: To be published. Google Scholar6. HahnEckhardtStowens EOGCD: The relationship of post-streptococcal electrocardiographic abnormalities to rheumatic fever and their reduction by antibiotic therapy. To be published. Google Scholar7. DennyWannamakerBrinkRammelkampCuster FWLWWRCHEA: Prevention of rheumatic fever. Treatment of the preceding streptococcic infection, J. A. M. A. 143: 151, 1950. CrossrefMedlineGoogle Scholar8. WannamakerRammelkampDennyBrinkHouserHahnDingle LWCHFWWRHBEOJH: Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin, Am. J. Med. 10: 673, 1951. CrossrefMedlineGoogle Scholar9. RammelkampHouserHahnWannamakerDennyEckhardt CHHBEOLWFWGC: Prevention of rheumatic fever. 1952, Symposium on Rheumatic Fever, University of Minnesota Press, Minneapolis. Google Scholar10. DennyWannamakerRammelkamp FWLWCH: The relation of antibody production to the development of rheumatic fever, Am. J. Dis. Child. 80: 506, 1950. Google Scholar11. Massell BF: Salicylates, hormones, and penicillin in the treatment of rheumatic fever, M. Clin. North America 34: 1419, 1950. CrossrefMedlineGoogle Scholar12. CoburnMoore AFLV: The prophylactic use of sulfanilamide in streptococcal respiratory infections, with especial reference to rheumatic fever, J. Clin. Investigation 18: 147, 1939. CrossrefMedlineGoogle Scholar13. ThomasFrance CBR: A preliminary report of the prophylactic use of sulfanilamide in patients susceptible to rheumatic fever, Bull. Johns Hopkins Hosp. 64: 67, 1939. Google Scholar14. DodgeBaldwinWeber KGJSMW: The prophylactic use of sulfanilamide in children with inactive rheumatic fever, J. Pediat. 24: 483, 1944. CrossrefGoogle Scholar15. Baldwin JS: Sulfadiazine prophylaxis in children and adolescents with inactive rheumatic fever, J. Pediat. 30: 284, 1947. CrossrefMedlineGoogle Scholar16. RubboHolmesStokes SDMCHL: Prophylactic sulfanilamide in rheumatic fever. Review of 548 cases, Lancet 2: 311, 1949. CrossrefMedlineGoogle Scholar17. Feldt RH: Sulfanilamide as prophylactic measure in recurrent rheumatic infection. Controlled study involving 131 "patient seasons," Am. J. M. Sc. 207: 483, 1944. CrossrefGoogle Scholar18. Maliner MM: Oral penicillin in the prophylaxis of recurrent rheumatic fever, J. Pediat. 37: 858, 1950. CrossrefMedlineGoogle Scholar19. KohnMilzerMacLean KHAH: Oral penicillin prophylaxis of recurrences of rheumatic fever, J. A. M. A. 142: 20, 1950. CrossrefMedlineGoogle Scholar20. Evans JA: Oral penicillin in the prophylaxis of streptococcal infections and rheumatic relapse, Proc. Roy. Soc. Med. 43: 206, 1950. CrossrefMedlineGoogle Scholar21. Streptococcal Disease Laboratory. Unpublished data. Google Scholar22. MassellSturgisKnoblochStreeperHallNorcross BFGPJDRBTNP: Prevention of rheumatic fever by prompt penicillin therapy of hemolytic streptococci respiratory infections. Progress report, J. A. M. A. 146: 1469, 1951. CrossrefMedlineGoogle Scholar23. Wilson MG: Rheumatic fever. Studies of the epidemiology, manifestations, diagnosis, and treatment of the disease during the first three decades, 1940, Commonwealth Fund, New York. Google Scholar24. WeinsteinBackrachBoyer LLNH: Observations on the development of rheumatic fever and glomerulonephritis in cases of scarlet fever treated with penicillin, New England J. Med. 242: 1002, 1950. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: *From the Symposium on Rheumatic Fever presented at the Thirty-third Annual Session of the American College of Physicians, Cleveland, Ohio, April 25, 1952.From the Streptococcal Disease Laboratory, Francis E. Warren Air Force Base, Wyoming, and Department of Preventive Medicine, Western Reserve University School of Medicine, Cleveland, Ohio.This investigation was conducted under the sponsorship of the Commission on Acute Respiratory Diseases and the Commission on Streptococcal Diseases, Armed Forces Epidemiological Board, and was supported by the Offices of The Surgeons General, Departments of the Army and Air Force, Washington, D. C. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByPrevention of Streptococcal Pharyngitis among Military Personnel and Their Civilian Dependents by Mass ProphylaxisRheumatic FeverHemolytic streptococcal infection and rheumatic feverControlled Studies of Streptococcal Pharyngitis in a Pediatric PopulationDie Prophylaxe der rheumatischen HerzkrankheitenThe SulfonamidesCurrent status of prophylaxis against rheumatic feverErkrankungen des EndokardPrevention of Rheumatic Fever and Bacterial Endocarditis Through Control of Streptococcal InfectionsThe Etiology and Prevention of Rheumatic FeverProphylaxis of Rheumatic Fever and Rheumatic Heart DiseaseA controlled study of beta hemolytic streptococcal infection in rheumatic familiesPrevention of Rheumatic Fever by Treatment of Streptococcal InfectionsEpidemiology of rheumatic feverPrevention of Rheumatic Fever and Bacterial Endocarditis Through Control of Streptococcal InfectionsThe use of antibiotics for the prevention of rheumatic feverSpecific Treatment of Infectious DiseasesAureomycin in the Prophylaxis of Rheumatic FeverDiagnosis and Prevention of Bacterial EndocarditisCurrent pediatric references 1 November 1952Volume 37, Issue 5Page: 1035-1043KeywordsChildrenDisabilitiesGroup A streptococcal infectionPreventive medicinePulmonary diseasesResearch laboratoriesRheumatic feverStreptococcal infectionsSurgeonsUpper respiratory tract infections Issue Published: 1 November 1952 PDF DownloadLoading ...